Obonyo C, Were V, Wamae P, Muok E
Antimicrob Agents Chemother. 2024; 69(2):e0073924.
PMID: 39699212
PMC: 11823657.
DOI: 10.1128/aac.00739-24.
Itoh K, Nakahara H, Takashino A, Hara A, Katsuno A, Abe Y
RSC Med Chem. 2024; .
PMID: 39399310
PMC: 11467761.
DOI: 10.1039/d4md00599f.
Rani V, Gehlawat V, Arya V
J Family Med Prim Care. 2024; 13(6):2300-2304.
PMID: 39027868
PMC: 11254057.
DOI: 10.4103/jfmpc.jfmpc_733_23.
Obonyo C, Rawago F, Makworo N, Muok E
Parasit Vectors. 2024; 17(1):279.
PMID: 38943214
PMC: 11212220.
DOI: 10.1186/s13071-024-06359-6.
Obonyo C, Were V, Wamae P, Muok E
Trials. 2023; 24(1):763.
PMID: 38012787
PMC: 10683197.
DOI: 10.1186/s13063-023-07790-3.
Revisiting the Dissolution of Praziquantel in Biorelevant Media and the Impact of Digestion of Milk on Drug Dissolution.
Eason T, Ramirez G, Clulow A, Salim M, Boyd B
Pharmaceutics. 2022; 14(10).
PMID: 36297662
PMC: 9609124.
DOI: 10.3390/pharmaceutics14102228.
Update on the diagnosis and management of neurocysticercosis.
Takayanagui O, Haes T
Arq Neuropsiquiatr. 2022; 80(5 Suppl 1):296-306.
PMID: 35976305
PMC: 9491409.
DOI: 10.1590/0004-282X-ANP-2022-S115.
Translating From Egg- to Antigen-Based Indicators for Elimination Targets: A Bayesian Latent Class Analysis Study.
Clark J, Moses A, Nankasi A, Faust C, Adriko M, Ajambo D
Front Trop Dis. 2022; 3:825721.
PMID: 35784267
PMC: 7612949.
DOI: 10.3389/fitd.2022.825721.
Improving anthelmintic treatment for schistosomiasis and soil-transmitted helminthiases through sharing and reuse of individual participant data.
Walker M, Freitas L, Halder J, Brack M, Keiser J, King C
Wellcome Open Res. 2022; 7:5.
PMID: 35493199
PMC: 9020536.
DOI: 10.12688/wellcomeopenres.17468.1.
R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini.
Falcoz C, Guzy S, Kovac J, Meister I, Coulibaly J, Sayasone S
J Pharmacokinet Pharmacodyn. 2022; 49(3):293-310.
PMID: 35024995
DOI: 10.1007/s10928-021-09791-8.
Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Infection.
Minzi O, Mnkugwe R, Ngaimisi E, Kinunghi S, Hansson A, Pohanka A
Pharmaceuticals (Basel). 2021; 14(5).
PMID: 33922522
PMC: 8145331.
DOI: 10.3390/ph14050400.
Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models.
Zdesenko G, Mutapi F
PLoS Negl Trop Dis. 2020; 14(9):e0008649.
PMID: 32976496
PMC: 7518612.
DOI: 10.1371/journal.pntd.0008649.
Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting.
Binder S, Campbell C, Castleman J, Kittur N, Kinunghi S, Olsen A
Am J Trop Med Hyg. 2020; 103(1_Suppl):105-113.
PMID: 32400352
PMC: 7351302.
DOI: 10.4269/ajtmh.19-0789.
The Schistosomiasis Consortium for Operational Research and Evaluation 2008-2020: Approaches, Experiences, Lessons, and Recommendations.
Binder S, Campbell C, S Andros T, Castleman J, Kittur N, King C
Am J Trop Med Hyg. 2020; 103(1_Suppl):114-124.
PMID: 32400350
PMC: 7351309.
DOI: 10.4269/ajtmh.19-0786.
Schistosomiasis and soil-transmitted helminthiasis preventive chemotherapy: Adverse events in children from 2 to 15 years in Bengo province, Angola.
Lemos M, Pedro J, Fancony C, Moura S, Brito M, Vaz Nery S
PLoS One. 2020; 15(3):e0229247.
PMID: 32160223
PMC: 7065752.
DOI: 10.1371/journal.pone.0229247.
The effect of ketoconazole on praziquantel pharmacokinetics and the role of CYP3A4 in the formation of X-OH-praziquantel and not 4-OH-praziquantel.
Nleya L, Thelingwani R, Li X, Cavallin E, Isin E, Nhachi C
Eur J Clin Pharmacol. 2019; 75(8):1077-1087.
PMID: 31089768
DOI: 10.1007/s00228-019-02663-8.
Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Zoghroban H, El-Kowrany S, Aboul Asaad I, El Maghraby G, El-Nouby K, Abd Elazeem M
Parasitol Res. 2018; 118(1):219-234.
PMID: 30421348
DOI: 10.1007/s00436-018-6132-z.
Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale.
Bonate P, Wang T, Passier P, Bagchus W, Burt H, Lupfert C
J Pharmacokinet Pharmacodyn. 2018; 45(5):747-762.
PMID: 30218416
PMC: 6182730.
DOI: 10.1007/s10928-018-9601-1.
Pharmacokinetics of Praziquantel in Schistosoma mansoni- and Schistosoma haematobium-Infected School- and Preschool-Aged Children.
Kovac J, Meister I, Neodo A, Panic G, Coulibaly J, Falcoz C
Antimicrob Agents Chemother. 2018; 62(8).
PMID: 29866859
PMC: 6105791.
DOI: 10.1128/AAC.02253-17.
A Review of Food-Drug Interactions on Oral Drug Absorption.
Deng J, Zhu X, Chen Z, Fan C, Kwan H, Wong C
Drugs. 2017; 77(17):1833-1855.
PMID: 29076109
DOI: 10.1007/s40265-017-0832-z.